Venetoclax and hypomethylating agent therapy for accelerated and blast phase BCR:ABL negative myeloproliferative and extramedullary disease. Issue 4 (21st March 2023)

Record Type:
Journal Article
Title:
Venetoclax and hypomethylating agent therapy for accelerated and blast phase BCR:ABL negative myeloproliferative and extramedullary disease. Issue 4 (21st March 2023)
Main Title:
Venetoclax and hypomethylating agent therapy for accelerated and blast phase BCR::ABL negative myeloproliferative and extramedullary disease
Authors:
Yeoh, Zhi-Han
Wei, Andrew
Abstract:
Is Part Of:
Leukemia & lymphoma. Volume 64:Issue 4(2023)
Journal:
Leukemia & lymphoma
Issue:
Volume 64:Issue 4(2023)
Issue Display:
Volume 64, Issue 4 (2023)
Year:
2023
Volume:
64
Issue:
4
Issue Sort Value:
2023-0064-0004-0000
Page Start:
757
Page End:
760
Publication Date:
2023-03-21
Subjects:
Leukemia -- Periodicals
Lymphomas -- Periodicals
616.99419
Journal URLs:
http://informahealthcare.com ↗
DOI:
10.1080/10428194.2023.2197533 ↗
Languages:
English
ISSNs:
1042-8194
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 5185.251500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
26994.xml